| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 19 | 2018 | 149 | 1.470 |
Why?
|
| Diabetic Neuropathies | 13 | 2010 | 58 | 1.400 |
Why?
|
| Peripheral Nervous System Diseases | 10 | 2011 | 124 | 1.180 |
Why?
|
| Sural Nerve | 7 | 2011 | 47 | 0.640 |
Why?
|
| Muscular Diseases | 5 | 2018 | 103 | 0.600 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 3 | 2019 | 7 | 0.460 |
Why?
|
| Receptors, Cholinergic | 1 | 2012 | 84 | 0.400 |
Why?
|
| Motor Neurons | 6 | 2000 | 138 | 0.380 |
Why?
|
| Myasthenia Gravis | 4 | 2009 | 73 | 0.380 |
Why?
|
| Electrophysiology | 2 | 2011 | 271 | 0.380 |
Why?
|
| Sensory Receptor Cells | 1 | 2011 | 53 | 0.350 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2009 | 10 | 0.330 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2009 | 28 | 0.330 |
Why?
|
| Autoantibodies | 1 | 2012 | 436 | 0.330 |
Why?
|
| Tramadol | 2 | 2000 | 9 | 0.320 |
Why?
|
| Pain | 6 | 2011 | 451 | 0.320 |
Why?
|
| Skin Ulcer | 1 | 2009 | 33 | 0.310 |
Why?
|
| Muscle Weakness | 2 | 2019 | 84 | 0.290 |
Why?
|
| Diabetic Foot | 1 | 2010 | 163 | 0.280 |
Why?
|
| Neural Conduction | 5 | 2012 | 92 | 0.250 |
Why?
|
| Analgesics, Opioid | 2 | 2000 | 404 | 0.230 |
Why?
|
| Diabetes Mellitus | 3 | 2010 | 874 | 0.220 |
Why?
|
| Muscles | 11 | 1996 | 292 | 0.210 |
Why?
|
| Iron-Binding Proteins | 2 | 1999 | 32 | 0.190 |
Why?
|
| Friedreich Ataxia | 2 | 1999 | 48 | 0.190 |
Why?
|
| Disease Progression | 5 | 2010 | 2064 | 0.180 |
Why?
|
| Humans | 76 | 2019 | 125154 | 0.180 |
Why?
|
| Neuromuscular Diseases | 4 | 1996 | 57 | 0.180 |
Why?
|
| Muscle, Skeletal | 3 | 2012 | 946 | 0.170 |
Why?
|
| Potassium Channel Blockers | 2 | 2019 | 84 | 0.160 |
Why?
|
| Cell Count | 1 | 2000 | 254 | 0.160 |
Why?
|
| Biopsy | 8 | 2010 | 1237 | 0.160 |
Why?
|
| Aged | 23 | 2018 | 19878 | 0.160 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2001 | 144 | 0.150 |
Why?
|
| Middle Aged | 32 | 2018 | 26939 | 0.150 |
Why?
|
| Brain Diseases | 2 | 1996 | 300 | 0.150 |
Why?
|
| Adult | 37 | 2018 | 29645 | 0.150 |
Why?
|
| Valosin Containing Protein | 1 | 2018 | 7 | 0.150 |
Why?
|
| Osteitis Deformans | 1 | 2018 | 7 | 0.150 |
Why?
|
| Deprescriptions | 1 | 2018 | 12 | 0.150 |
Why?
|
| Mutation, Missense | 2 | 2018 | 875 | 0.140 |
Why?
|
| Trinucleotide Repeats | 1 | 1998 | 109 | 0.140 |
Why?
|
| Vasculitis | 2 | 2009 | 49 | 0.140 |
Why?
|
| Lower Extremity | 1 | 2019 | 187 | 0.140 |
Why?
|
| Median Nerve | 1 | 1997 | 16 | 0.140 |
Why?
|
| Myoclonus | 1 | 1997 | 32 | 0.140 |
Why?
|
| Neuromuscular Agents | 1 | 2018 | 67 | 0.140 |
Why?
|
| Electromyography | 3 | 2012 | 165 | 0.130 |
Why?
|
| Male | 44 | 2018 | 61506 | 0.130 |
Why?
|
| Cholinesterases | 1 | 1996 | 10 | 0.130 |
Why?
|
| Neuromuscular Junction Diseases | 1 | 2015 | 1 | 0.130 |
Why?
|
| Mosaicism | 1 | 1998 | 239 | 0.130 |
Why?
|
| Orphan Drug Production | 1 | 2015 | 5 | 0.130 |
Why?
|
| 4-Aminopyridine | 1 | 2015 | 32 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1998 | 369 | 0.130 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 1997 | 199 | 0.130 |
Why?
|
| Clinical Trials as Topic | 2 | 2000 | 1101 | 0.120 |
Why?
|
| Plasma Exchange | 2 | 1996 | 84 | 0.120 |
Why?
|
| Myotonic Dystrophy | 2 | 1996 | 149 | 0.120 |
Why?
|
| Autonomic Nervous System Diseases | 4 | 1988 | 43 | 0.120 |
Why?
|
| Immunosuppressive Agents | 2 | 1998 | 650 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 1998 | 250 | 0.120 |
Why?
|
| Meningitis, Aseptic | 1 | 1995 | 13 | 0.120 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 6603 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 1996 | 203 | 0.120 |
Why?
|
| Palliative Care | 1 | 1998 | 432 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 1996 | 225 | 0.110 |
Why?
|
| Double-Blind Method | 7 | 2018 | 1638 | 0.110 |
Why?
|
| Female | 31 | 2018 | 66786 | 0.110 |
Why?
|
| Frontal Lobe | 2 | 2010 | 116 | 0.100 |
Why?
|
| Temporal Lobe | 2 | 2010 | 113 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 369 | 0.100 |
Why?
|
| Action Potentials | 2 | 2011 | 502 | 0.100 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1992 | 14 | 0.100 |
Why?
|
| Paralysis | 1 | 1992 | 35 | 0.100 |
Why?
|
| Autoimmune Diseases | 3 | 1986 | 250 | 0.090 |
Why?
|
| Risk Factors | 6 | 2010 | 10310 | 0.090 |
Why?
|
| Reflex | 1 | 2011 | 51 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2018 | 690 | 0.090 |
Why?
|
| Speech Articulation Tests | 1 | 2010 | 8 | 0.090 |
Why?
|
| Verbal Behavior | 1 | 2010 | 52 | 0.080 |
Why?
|
| Peripheral Nerves | 4 | 1998 | 85 | 0.080 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2009 | 7 | 0.080 |
Why?
|
| Physicians | 1 | 2015 | 587 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum | 2 | 1989 | 196 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1999 | 73 | 0.080 |
Why?
|
| Myelin Sheath | 3 | 1992 | 122 | 0.080 |
Why?
|
| Receptors, Eph Family | 1 | 2008 | 20 | 0.080 |
Why?
|
| Galvanic Skin Response | 1 | 1988 | 9 | 0.070 |
Why?
|
| Amyloidosis | 1 | 2009 | 72 | 0.070 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2008 | 88 | 0.070 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 120 | 0.070 |
Why?
|
| Pedigree | 4 | 2018 | 1605 | 0.070 |
Why?
|
| Respiratory Paralysis | 1 | 1987 | 7 | 0.070 |
Why?
|
| Vasa Nervorum | 1 | 1986 | 1 | 0.070 |
Why?
|
| Collagen Diseases | 1 | 1986 | 4 | 0.070 |
Why?
|
| Thymectomy | 2 | 1984 | 23 | 0.070 |
Why?
|
| Pyridoxine | 1 | 1986 | 14 | 0.070 |
Why?
|
| Blood Vessels | 1 | 1986 | 104 | 0.070 |
Why?
|
| Lymphocytes | 3 | 1999 | 410 | 0.060 |
Why?
|
| Spinal Nerves | 1 | 1986 | 5 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 445 | 0.060 |
Why?
|
| Dermatomyositis | 1 | 1986 | 21 | 0.060 |
Why?
|
| Hydrazines | 1 | 1986 | 30 | 0.060 |
Why?
|
| Thorax | 1 | 1986 | 73 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 1896 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2056 | 0.060 |
Why?
|
| Abdomen | 1 | 1986 | 127 | 0.060 |
Why?
|
| Polyneuropathies | 1 | 1985 | 29 | 0.060 |
Why?
|
| Transfusion Reaction | 1 | 2005 | 42 | 0.060 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 1998 | 80 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 1986 | 121 | 0.060 |
Why?
|
| Survival Rate | 1 | 2010 | 2064 | 0.060 |
Why?
|
| Prednisone | 3 | 1993 | 276 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2000 | 1585 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 2174 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2010 | 1565 | 0.060 |
Why?
|
| Persian Gulf Syndrome | 1 | 2003 | 15 | 0.050 |
Why?
|
| Warfare | 1 | 2003 | 34 | 0.050 |
Why?
|
| Eosinophilia-Myalgia Syndrome | 2 | 1993 | 2 | 0.050 |
Why?
|
| Calcinosis | 1 | 1984 | 178 | 0.050 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2003 | 80 | 0.050 |
Why?
|
| Ophthalmoplegia | 1 | 2003 | 54 | 0.050 |
Why?
|
| West Nile Fever | 1 | 2005 | 139 | 0.050 |
Why?
|
| Neurologic Examination | 3 | 1992 | 193 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2003 | 125 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 714 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2003 | 185 | 0.050 |
Why?
|
| Point Mutation | 1 | 2003 | 348 | 0.050 |
Why?
|
| Young Adult | 2 | 2018 | 9059 | 0.050 |
Why?
|
| Xenon | 1 | 1981 | 12 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 1981 | 44 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2892 | 0.050 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2001 | 4 | 0.050 |
Why?
|
| Myotonia Congenita | 1 | 2000 | 5 | 0.050 |
Why?
|
| Patient Care | 1 | 2001 | 99 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2008 | 1526 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2010 | 3465 | 0.040 |
Why?
|
| Chloride Channels | 1 | 2000 | 62 | 0.040 |
Why?
|
| DNA | 2 | 1997 | 1608 | 0.040 |
Why?
|
| Microscopy, Electron | 3 | 1996 | 395 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 2 | 1996 | 122 | 0.040 |
Why?
|
| Influenza, Human | 1 | 1986 | 661 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 1979 | 25 | 0.040 |
Why?
|
| Cyclosporins | 2 | 1989 | 74 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 1999 | 125 | 0.040 |
Why?
|
| Sleep | 2 | 1998 | 345 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 819 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 1979 | 187 | 0.040 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 1978 | 6 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2005 | 860 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2000 | 346 | 0.040 |
Why?
|
| Myositis | 1 | 1979 | 62 | 0.040 |
Why?
|
| Blood Glucose | 2 | 1996 | 1133 | 0.040 |
Why?
|
| Maintenance Chemotherapy | 1 | 2018 | 20 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 1981 | 463 | 0.040 |
Why?
|
| Genetic Carrier Screening | 1 | 1998 | 68 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1997 | 92 | 0.030 |
Why?
|
| Electrodiagnosis | 1 | 1997 | 9 | 0.030 |
Why?
|
| Toes | 1 | 1997 | 28 | 0.030 |
Why?
|
| Pressure | 1 | 1997 | 131 | 0.030 |
Why?
|
| Introns | 1 | 1998 | 300 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 1270 | 0.030 |
Why?
|
| Diabetic Coma | 1 | 1996 | 2 | 0.030 |
Why?
|
| Axons | 2 | 1992 | 369 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2001 | 1179 | 0.030 |
Why?
|
| Nerve Endings | 1 | 1996 | 8 | 0.030 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 1996 | 6 | 0.030 |
Why?
|
| Succinylcholine | 1 | 1996 | 3 | 0.030 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1996 | 5 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 1997 | 326 | 0.030 |
Why?
|
| Isoquinolines | 1 | 1996 | 40 | 0.030 |
Why?
|
| Thiazoles | 1 | 1996 | 98 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 1998 | 5177 | 0.030 |
Why?
|
| Homozygote | 1 | 1998 | 547 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 1998 | 405 | 0.030 |
Why?
|
| Age of Onset | 2 | 2010 | 594 | 0.030 |
Why?
|
| Motor Neuron Disease | 1 | 1995 | 15 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2001 | 731 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1996 | 232 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1996 | 163 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 1998 | 329 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1995 | 160 | 0.030 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1996 | 160 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2010 | 12392 | 0.030 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 1994 | 30 | 0.030 |
Why?
|
| Time Factors | 4 | 2001 | 6331 | 0.030 |
Why?
|
| Drug Stability | 1 | 1993 | 58 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1993 | 85 | 0.030 |
Why?
|
| Blood Cells | 1 | 1993 | 50 | 0.030 |
Why?
|
| Base Sequence | 2 | 1999 | 3102 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1993 | 215 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1993 | 168 | 0.030 |
Why?
|
| Mass Screening | 1 | 2019 | 785 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 1997 | 1327 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 1994 | 282 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 3891 | 0.030 |
Why?
|
| Anesthesia | 1 | 1996 | 207 | 0.030 |
Why?
|
| Phosphatidylinositols | 1 | 1992 | 31 | 0.030 |
Why?
|
| Immune System | 1 | 1993 | 90 | 0.030 |
Why?
|
| Kynurenine | 1 | 1992 | 21 | 0.030 |
Why?
|
| Tryptophan | 1 | 1992 | 91 | 0.020 |
Why?
|
| Muscle Hypotonia | 2 | 1985 | 187 | 0.020 |
Why?
|
| Neoplasms | 1 | 1986 | 2793 | 0.020 |
Why?
|
| Veterans | 1 | 2003 | 1753 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1992 | 137 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2912 | 0.020 |
Why?
|
| Calcium | 1 | 1996 | 1102 | 0.020 |
Why?
|
| Frontotemporal Dementia | 1 | 2010 | 43 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2003 | 794 | 0.020 |
Why?
|
| Age Factors | 3 | 1989 | 2821 | 0.020 |
Why?
|
| Mitochondria | 1 | 1994 | 680 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2010 | 182 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 233 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 398 | 0.020 |
Why?
|
| Alleles | 1 | 1993 | 1615 | 0.020 |
Why?
|
| Phenytoin | 2 | 1986 | 63 | 0.020 |
Why?
|
| Quality of Life | 1 | 1998 | 1941 | 0.020 |
Why?
|
| Lipoproteins | 1 | 1989 | 180 | 0.020 |
Why?
|
| Valsalva Maneuver | 1 | 1988 | 9 | 0.020 |
Why?
|
| Hypotension, Orthostatic | 1 | 1988 | 21 | 0.020 |
Why?
|
| United States | 2 | 2001 | 10916 | 0.020 |
Why?
|
| Cell Line | 2 | 2008 | 2758 | 0.020 |
Why?
|
| Prognosis | 2 | 1992 | 4642 | 0.020 |
Why?
|
| Aldehyde Reductase | 1 | 1987 | 17 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 1987 | 50 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2008 | 167 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 521 | 0.020 |
Why?
|
| Protein Folding | 1 | 2008 | 215 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3157 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 312 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 217 | 0.020 |
Why?
|
| Mutation | 1 | 2000 | 5848 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1992 | 865 | 0.020 |
Why?
|
| Hallucinations | 1 | 1987 | 26 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 539 | 0.020 |
Why?
|
| Intercostal Nerves | 1 | 1986 | 8 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 223 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 924 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 767 | 0.020 |
Why?
|
| Azathioprine | 1 | 1986 | 54 | 0.020 |
Why?
|
| Visual Perception | 1 | 1987 | 124 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2010 | 552 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 1986 | 94 | 0.020 |
Why?
|
| Joint Instability | 1 | 1985 | 42 | 0.020 |
Why?
|
| Pseudotumor Cerebri | 1 | 1986 | 58 | 0.010 |
Why?
|
| Muscular Atrophy | 1 | 1985 | 75 | 0.010 |
Why?
|
| Basal Ganglia Diseases | 1 | 1984 | 27 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 1985 | 193 | 0.010 |
Why?
|
| Microtubules | 1 | 1985 | 189 | 0.010 |
Why?
|
| Models, Neurological | 1 | 1986 | 216 | 0.010 |
Why?
|
| Brain | 1 | 1996 | 2999 | 0.010 |
Why?
|
| Ischemic Attack, Transient | 1 | 1984 | 57 | 0.010 |
Why?
|
| Globosides | 1 | 1984 | 1 | 0.010 |
Why?
|
| Glycosphingolipids | 1 | 1984 | 11 | 0.010 |
Why?
|
| Indian Ocean | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1996 | 1697 | 0.010 |
Why?
|
| DNA Primase | 1 | 2003 | 21 | 0.010 |
Why?
|
| DNA Polymerase gamma | 1 | 2003 | 10 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1986 | 417 | 0.010 |
Why?
|
| Gait | 1 | 1984 | 146 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 144 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2003 | 64 | 0.010 |
Why?
|
| Animals | 5 | 2008 | 34222 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2008 | 769 | 0.010 |
Why?
|
| Phenotype | 2 | 2003 | 4263 | 0.010 |
Why?
|
| Creatine Kinase | 2 | 1980 | 58 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 657 | 0.010 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 1982 | 14 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2003 | 228 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2003 | 453 | 0.010 |
Why?
|
| DNA Helicases | 1 | 2003 | 231 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 347 | 0.010 |
Why?
|
| Risk | 1 | 2003 | 756 | 0.010 |
Why?
|
| Paraplegia | 1 | 1981 | 95 | 0.010 |
Why?
|
| Sex Factors | 2 | 1988 | 1288 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1981 | 133 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 1078 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1982 | 294 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1984 | 677 | 0.010 |
Why?
|
| Malignant Hyperthermia | 1 | 1980 | 19 | 0.010 |
Why?
|
| Poly A | 1 | 1999 | 59 | 0.010 |
Why?
|
| Myoglobinuria | 1 | 1979 | 2 | 0.010 |
Why?
|
| Frozen Sections | 1 | 1979 | 24 | 0.010 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 1979 | 25 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1979 | 44 | 0.010 |
Why?
|
| Pyridostigmine Bromide | 1 | 1979 | 13 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 1981 | 200 | 0.010 |
Why?
|
| Thyroid Function Tests | 1 | 1979 | 19 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1986 | 1043 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1979 | 82 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1979 | 62 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2003 | 813 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1979 | 157 | 0.010 |
Why?
|
| Adolescent | 3 | 2001 | 19355 | 0.010 |
Why?
|
| Cardiovascular Diseases | 2 | 1987 | 1968 | 0.010 |
Why?
|
| Random Allocation | 2 | 1989 | 440 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 2564 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1999 | 702 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1984 | 2102 | 0.010 |
Why?
|
| Riluzole | 1 | 1996 | 21 | 0.010 |
Why?
|
| Liver | 2 | 1996 | 1745 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 1996 | 7 | 0.010 |
Why?
|
| Sarcolemma | 1 | 1996 | 24 | 0.010 |
Why?
|
| Acrylic Resins | 1 | 1996 | 25 | 0.010 |
Why?
|
| Myotonin-Protein Kinase | 1 | 1996 | 45 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 3146 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 309 | 0.010 |
Why?
|
| Dihydropyridines | 1 | 1995 | 8 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 1996 | 76 | 0.010 |
Why?
|
| Amino Acids | 1 | 1978 | 668 | 0.010 |
Why?
|
| Ion Channel Gating | 1 | 1995 | 122 | 0.010 |
Why?
|
| Tetramethylphenylenediamine | 1 | 1994 | 1 | 0.010 |
Why?
|
| Malates | 1 | 1994 | 6 | 0.010 |
Why?
|
| Pyruvates | 1 | 1994 | 22 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 4820 | 0.010 |
Why?
|
| Pyruvic Acid | 1 | 1994 | 38 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1994 | 78 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1999 | 3054 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1993 | 43 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1994 | 107 | 0.010 |
Why?
|
| Solubility | 1 | 1993 | 139 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 998 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1996 | 584 | 0.010 |
Why?
|
| Rats | 2 | 1996 | 3716 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1992 | 17 | 0.010 |
Why?
|
| Autoradiography | 1 | 1992 | 69 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 1304 | 0.010 |
Why?
|
| Quinolinic Acid | 1 | 1992 | 10 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 771 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1996 | 1241 | 0.010 |
Why?
|
| Child | 4 | 1986 | 24393 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1981 | 1216 | 0.010 |
Why?
|
| Kinetics | 1 | 1994 | 1332 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1996 | 1631 | 0.010 |
Why?
|
| Scleroderma, Systemic | 1 | 1992 | 119 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1992 | 319 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1992 | 506 | 0.010 |
Why?
|
| Electrocardiography | 2 | 1986 | 979 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1985 | 14011 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1989 | 144 | 0.000 |
Why?
|
| Lipoproteins, LDL | 1 | 1989 | 129 | 0.000 |
Why?
|
| Fasting | 1 | 1989 | 293 | 0.000 |
Why?
|
| Placebos | 1 | 1988 | 241 | 0.000 |
Why?
|
| Triglycerides | 1 | 1989 | 575 | 0.000 |
Why?
|
| Death, Sudden | 1 | 1986 | 45 | 0.000 |
Why?
|
| Cholesterol | 1 | 1989 | 541 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1988 | 729 | 0.000 |
Why?
|
| Sweating | 1 | 1986 | 7 | 0.000 |
Why?
|
| Body Temperature Regulation | 1 | 1986 | 40 | 0.000 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 1986 | 46 | 0.000 |
Why?
|
| Diabetic Angiopathies | 1 | 1986 | 65 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2003 | 16334 | 0.000 |
Why?
|
| Pupil | 1 | 1986 | 71 | 0.000 |
Why?
|
| Biological Transport | 1 | 1986 | 356 | 0.000 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1986 | 79 | 0.000 |
Why?
|
| Vision Disorders | 1 | 1987 | 211 | 0.000 |
Why?
|
| Thallium | 1 | 1984 | 9 | 0.000 |
Why?
|
| Radioisotopes | 1 | 1984 | 39 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1984 | 149 | 0.000 |
Why?
|
| Cataract | 1 | 1987 | 224 | 0.000 |
Why?
|
| Carbohydrate Conformation | 1 | 1984 | 16 | 0.000 |
Why?
|
| Carbohydrate Sequence | 1 | 1984 | 18 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1984 | 43 | 0.000 |
Why?
|
| Glycolipids | 1 | 1984 | 32 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1984 | 101 | 0.000 |
Why?
|
| Carbamazepine | 1 | 1983 | 48 | 0.000 |
Why?
|
| Reference Values | 1 | 1984 | 715 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1987 | 816 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1986 | 337 | 0.000 |
Why?
|
| Body Water | 1 | 1982 | 90 | 0.000 |
Why?
|
| Coronary Angiography | 1 | 1984 | 449 | 0.000 |
Why?
|
| Chickens | 1 | 1982 | 636 | 0.000 |
Why?
|
| Aorta, Abdominal | 1 | 1981 | 126 | 0.000 |
Why?
|
| Seizures | 1 | 1986 | 871 | 0.000 |
Why?
|
| Syndrome | 1 | 1983 | 1120 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1984 | 850 | 0.000 |
Why?
|
| Palmitoylcarnitine | 1 | 1979 | 6 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 1984 | 769 | 0.000 |
Why?
|
| Mitochondria, Muscle | 1 | 1979 | 34 | 0.000 |
Why?
|
| Mitochondria, Liver | 1 | 1979 | 31 | 0.000 |
Why?
|
| Muscle Contraction | 1 | 1980 | 190 | 0.000 |
Why?
|
| Carnitine | 1 | 1979 | 74 | 0.000 |
Why?
|
| Mice | 1 | 1996 | 17635 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1982 | 466 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1989 | 6158 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1979 | 462 | 0.000 |
Why?
|
| Recurrence | 1 | 1979 | 1421 | 0.000 |
Why?
|